The latest study in the field of lung cancer has revealed that an immune system-based treatment for lung cancer, worked better in people who were overweight in some trials. In the medical context, obesity might have given patients a little advance, new research suggests. Australian researchers have looked at trials of atezolizumab involving 2100 people